BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16005468)

  • 1. Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL.
    Gagarin D; Yang Z; Butler J; Wimmer M; Du B; Cahan P; McCaffrey TA
    J Mol Cell Cardiol; 2005 Sep; 39(3):453-65. PubMed ID: 16005468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to fas-induced apoptosis in cells from human atherosclerotic lesions: elevated Bcl-XL inhibits apoptosis and caspase activation.
    Yang Z; Gagarin D; Ramezani A; Hawley RG; McCaffrey TA
    J Vasc Res; 2007; 44(6):483-94. PubMed ID: 17657164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells.
    de Groot RP; Raaijmakers JA; Lammers JW; Koenderman L
    Mol Cell Biol Res Commun; 2000 May; 3(5):299-305. PubMed ID: 10964754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells.
    Pu YS; Hour TC; Chuang SE; Cheng AL; Lai MK; Kuo ML
    Prostate; 2004 Jul; 60(2):120-9. PubMed ID: 15162378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 overexpression induces epidermal growth factor-independent resistance to apoptosis linked to BCL-2 in human A431 carcinoma.
    Rieber M; Rieber MS
    Apoptosis; 2006 Jan; 11(1):121-9. PubMed ID: 16374552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
    Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
    J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells.
    Huang M; Page C; Reynolds RK; Lin J
    Gynecol Oncol; 2000 Oct; 79(1):67-73. PubMed ID: 11006034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma].
    Ma XT; Wang S; Ye YJ; Du RY; Cui ZR
    Ai Zheng; 2003 Nov; 22(11):1135-9. PubMed ID: 14613639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
    Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B.
    Joung YH; Lim EJ; Kim MS; Lim SD; Yoon SY; Lim YC; Yoo YB; Ye SK; Park T; Chung IM; Bae KY; Yang YM
    Int J Oncol; 2008 Sep; 33(3):477-84. PubMed ID: 18695876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
    Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligonucleotide inhibition of Bcl-xL and Bid expression in liver regulates responses in a mouse model of Fas-induced fulminant hepatitis.
    Zhang H; Taylor J; Luther D; Johnston J; Murray S; Wyatt JR; Watt AT; Koo S; York-DeFalco C; Stecker K; Dean NM
    J Pharmacol Exp Ther; 2003 Oct; 307(1):24-33. PubMed ID: 12893848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.
    Quintanilla-Martinez L; Kremer M; Specht K; Calzada-Wack J; Nathrath M; Schaich R; Höfler H; Fend F
    Am J Pathol; 2003 May; 162(5):1449-61. PubMed ID: 12707028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Bad-mediated apoptosis by Sindbis virus infection: involvement of pro-survival members of the Bcl-2 family.
    Moriishi K; Koura M; Matsuura Y
    Virology; 2002 Jan; 292(2):258-71. PubMed ID: 11878929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIEG1 facilitates transforming growth factor-beta-mediated apoptosis in the oligodendroglial cell line OLI-neu.
    Bender H; Wang Z; Schuster N; Krieglstein K
    J Neurosci Res; 2004 Feb; 75(3):344-52. PubMed ID: 14743447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-apoptotic molecules Bcl-xL and Bcl-w target protein phosphatase 1alpha to Bad.
    Ayllón V; Cayla X; García A; Fleischer A; Rebollo A
    Eur J Immunol; 2002 Jul; 32(7):1847-55. PubMed ID: 12115603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of antiapoptotic genes in human endometrial carcinoma: bcl-XL succeeds bcl-2 function in neoplastic cells.
    Crescenzi E; Criniti V; Pianese M; Tecce MF; Palumbo G
    Gynecol Oncol; 2000 Jun; 77(3):419-28. PubMed ID: 10831353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions.
    Figueroa B; Chen S; Oyler GA; Hardwick JM; Betenbaugh MJ
    Biotechnol Bioeng; 2004 Mar; 85(6):589-600. PubMed ID: 14966800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.